Abstract:Purpose: To validate in the clinic the Adaptive Optics Visual Simulator VAO (Voptica SL, Murcia, Spain). Setting: Laboratory of Clinical Optics, University of Murcia, Spain. Methods: Adaptive optics visual simulators have been widely used in research laboratories for various applications within the visual sciences, however, their use in clinical practice has been limited. Recently, an Adaptive Optics Visual Simulator (VAO, Voptica S.L) has been commercially introduced as a medical device for clinical use. VAO combines optical measurements and visual testing within the same compact instrument. It incorporates a Hartmann‐Shack wave‐front sensor to measure objective refraction and aberrations, together with a spatial light modulator capable of correcting or inducing any optical profile while performing visual testing. In seventy‐six eyes from 38 subjects, subjective refraction (SR) was measured using VAO and trial frame as a gold standard (GS). The agreement of spherical equivalent (M) and cross cylinders (J0 and J45) between SR with VAO and with the GS was estimated using different statistic parameters: 95% confidence limits (CL), Student's t ‐test or Wilcoxon Rank Sum and Pearson correlation coefficient ( r ). Results: There was a strong correlation ( r ranged between 0.88 and 0.99) for subjective refraction (M, J0, J45) between GS and VAO and there were not statistically significant differences ( p > 0.05). The 95% CL of M, J0 and J45 were ±0.58, ±0.14 and ±0.14 D respectively. In addition to the subjective refraction, the visual acuity was also validated comparing BCVA values from GS with those from VAO, a high correlation ( ρ = 0.73) was found for BCVA between both methods. Individual differences in BCVA between both methods were around or below 1 line since 95% CI was ±0.10 LogMAR. Conclusions: Our findings suggest that VAO, the new instrument for vision analysis based on adaptive optics, provides measurements that are comparable to those of the gold standard technique in healthy eyes with 73.7% of the spherical equivalent (M) differences between them within ±0.25 D and 68.4% for BCVA within ±0.05 LogMAR. Thus, subjective refraction found with VAO can be used for prescribing, as a baseline to simulate any optical profile and to customize the selection of the ablation and the IOL design in refractive surgery.

Clinical Evaluation of a New Spectral-Domain Optical Coherence Tomography-Based Biometer

Evaluation of a New All-in-One Optical Biometer and Comparison With a Validated Swept-source OCT Biometer

Comparative analysis of a novel spectral-domain OCT biometer versus swept-source OCT or OLCR biometer in healthy pediatric ocular biometry

Agreement Between a New Optical Low Coherence Reflectometry Biometer and an Anterior Segment Optical Coherence Tomographer

Repeatability and Reproducibility of a New Fully Automatic Measurement Optical Low Coherence Reflectometry Biometer and Agreement with Swept-Source Optical Coherence Tomography-Based Biometer.

Comparison of Precision, Agreement, and Accuracy of Two Swept-Source Optical Coherence Tomography Biometers

Swept-Source Optical Coherence Tomography Biometer as Screening Strategy for Macular Disease in Patients Scheduled for Cataract Surgery

Evaluation of a new dynamic real-time visualization 25 kHz swept-source optical coherence tomography based biometer

Swept-source optical coherence tomography in ocular surface diseases: anterior segment analysis repeatability and its limits

Anterior segment biometry during accommodation imaged with ultralong scan depth optical coherence tomography.

Introduction and Validation of Low-Cost Ocular Biometry in Healthy and Cataractous Eyes Using a Thermally-Tunable Swept-Source Laser

Biometry-Based Technique for Determining the Anterior Scleral Thickness: Validation Using Optical Coherence Tomography Landmarks

Whole eye segment imaging and measurement with dual-channel spectral-domain OCT.

Clinical validation of an adaptive optics visual simulator ( VAO ), a new instrument for the clinic

Assessment of corneal epithelial thickness mapping by spectral-domain optical coherence tomography

Intrasession repeatability and agreement of the anterior corneal assessment provided by a multidiagnostic device

Comparison of ocular biometric parameters between two swept-source optical coherence tomography devices and Scheimpflug tomography in patients with cataract

Full anterior segment biometry with extended imaging range spectral domain optical coherence tomography at 1340 nm.

Comprehensive Comparisons of Ocular Biometry: A Network-Based Big Data Analysis.

Agreement between a new fully automatic ocular biometer based on optical low-coherence reflectometry and an optical biometer based on Scheimpflug imaging combined with partial coherence interferometry